Regulatory misalignment is one of the more preventable risks in development, which is exactly why it's so frustrating when it occurs. Sponsors who get this right build regulatory strategy into the program from day one rather than treating it as something to clean up once the science is settled. Every meaningful decision population, endpoints, statistical plan, biomarker strategy, safety monitoring, even manufacturing carries regulatory weight that compounds as the program advances.
Why Clinical Development Programs Fail Before FDA Ever Reviews the Data A Strategic Perspective on Evidence Generation, Regulatory Alignment, and Development Success Denis...
Excepteur sint occaecat cupidatat non proident